Increasing Cancer Screening Among Female Patients at PSH St. Joseph's Residency Clinic: Offering a Self-sampling Option in Clinic

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Maximum Age: 65
Healthy Volunteers: f
View:

• Eligible but out-of-date for cervical cancer screening

• Able to speak, read, and communicate well in English or Spanish

• Not at greater than average risk for cervical cancer

Locations
United States
Pennsylvania
Penn State Health St. Joseph's
RECRUITING
Reading
Contact Information
Primary
Christina Scartozzi, DO
cscartozzi@pennstatehealth.psu.edu
610-208-4610
Backup
Leonard Kishel
lkishel@pennstatehealth.psu.edu
717-531-0003
Time Frame
Start Date: 2023-09-18
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 50
Treatments
Experimental: Requested self-sampled HPV test
This group will receive the self-sampled HPV test. Included with the test are the test instructions, a lab requisition form, and a pre-paid mailer so that it can be sent back to the lab for testing. Results of the test will be shared with the participant.
Related Therapeutic Areas
Sponsors
Leads: Milton S. Hershey Medical Center

This content was sourced from clinicaltrials.gov